001     127492
005     20240228140931.0
024 7 _ |a 10.1016/j.canep.2015.05.009
|2 doi
024 7 _ |a pmid:26164654
|2 pmid
024 7 _ |a 1877-7821
|2 ISSN
024 7 _ |a 1877-783X
|2 ISSN
024 7 _ |a altmetric:4269430
|2 altmetric
037 _ _ |a DKFZ-2017-03515
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Schüz, Joachim
|b 0
245 _ _ |a European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk.
260 _ _ |a Amsterdam [u.a.]
|c 2015
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521712472_2108
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a This overview describes the principles of the 4th edition of the European Code against Cancer and provides an introduction to the 12 recommendations to reduce cancer risk. Among the 504.6 million inhabitants of the member states of the European Union (EU28), there are annually 2.64 million new cancer cases and 1.28 million deaths from cancer. It is estimated that this cancer burden could be reduced by up to one half if scientific knowledge on causes of cancer could be translated into successful prevention. The Code is a preventive tool aimed to reduce the cancer burden by informing people how to avoid or reduce carcinogenic exposures, adopt behaviours to reduce the cancer risk, or to participate in organised intervention programmes. The Code should also form a base to guide national health policies in cancer prevention. The 12 recommendations are: not smoking or using other tobacco products; avoiding second-hand smoke; being a healthy body weight; encouraging physical activity; having a healthy diet; limiting alcohol consumption, with not drinking alcohol being better for cancer prevention; avoiding too much exposure to ultraviolet radiation; avoiding cancer-causing agents at the workplace; reducing exposure to high levels of radon; encouraging breastfeeding; limiting the use of hormone replacement therapy; participating in organised vaccination programmes against hepatitis B for newborns and human papillomavirus for girls; and participating in organised screening programmes for bowel cancer, breast cancer, and cervical cancer.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Espina, Carolina
|b 1
700 1 _ |a Villain, Patricia
|b 2
700 1 _ |a Herrero, Rolando
|b 3
700 1 _ |a Leon, Maria E
|b 4
700 1 _ |a Minozzi, Silvia
|b 5
700 1 _ |a Romieu, Isabelle
|b 6
700 1 _ |a Segnan, Nereo
|b 7
700 1 _ |a Wardle, Jane
|b 8
700 1 _ |a Wiseman, Martin
|b 9
700 1 _ |a Belardelli, Filippo
|b 10
700 1 _ |a Bettcher, Douglas
|b 11
700 1 _ |a Cavalli, Franco
|b 12
700 1 _ |a Galea, Gauden
|b 13
700 1 _ |a Lenoir, Gilbert
|b 14
700 1 _ |a Martin-Moreno, Jose M
|b 15
700 1 _ |a Nicula, Florian Alexandru
|b 16
700 1 _ |a Olsen, Jørgen H
|b 17
700 1 _ |a Patnick, Julietta
|b 18
700 1 _ |a Primic-Zakelj, Maja
|b 19
700 1 _ |a Puska, Pekka
|b 20
700 1 _ |a van Leeuwen, Flora E
|b 21
700 1 _ |a Wiestler, Otmar
|0 P:(DE-He78)86e3d284d2b1dc72c5965f3b4f909ddb
|b 22
|u dkfz
700 1 _ |a Zatonski, Witold
|b 23
700 1 _ |a Experts, Working Groups of Scientific
|b 24
|e Collaboration Author
773 _ _ |a 10.1016/j.canep.2015.05.009
|g Vol. 39 Suppl 1, p. S1 - S10
|0 PERI:(DE-600)2498032-8
|p S1 - S10
|t Cancer epidemiology
|v 39 Suppl 1
|y 2015
|x 1877-7821
909 C O |o oai:inrepo02.dkfz.de:127492
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)86e3d284d2b1dc72c5965f3b4f909ddb
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEMIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)M010-20160331
|k M010
|l Stiftungsvorstand
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M010-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21